ECSP15033649A - Un medicamento combinado que comprende fenilefrina y paracetamol - Google Patents
Un medicamento combinado que comprende fenilefrina y paracetamolInfo
- Publication number
- ECSP15033649A ECSP15033649A ECIEPI201533649A ECPI201533649A ECSP15033649A EC SP15033649 A ECSP15033649 A EC SP15033649A EC IEPI201533649 A ECIEPI201533649 A EC IEPI201533649A EC PI201533649 A ECPI201533649 A EC PI201533649A EC SP15033649 A ECSP15033649 A EC SP15033649A
- Authority
- EC
- Ecuador
- Prior art keywords
- phenylephrine
- paracetamol
- pharmaceutically acceptable
- combination
- equivalent amount
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 6
- 229960005489 paracetamol Drugs 0.000 title abstract 6
- 229960001802 phenylephrine Drugs 0.000 title abstract 6
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 title abstract 6
- 229940126601 medicinal product Drugs 0.000 title 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 abstract 5
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 229940000425 combination drug Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
El uso del hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina) y paracetamol en la producción de un medicamento combinado para el tratamiento de la congestión de las mucosas de las vías respiratorias superiores, medicamento que comprende la combinación de tales sustancias con excipientes, caracterizado porque el medicamento contiene el hidrocloruro de fenilefrina (o la cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina) y paracetamol en las proporciones adecuadas para, y el medicamento es para, suministrarle a un adulto: a) 4 mg - 7,5 mg de hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina), en combinación con 950 mg - 1000 mg de paracetamol; o b) 5 mg - 7,5 mg de hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina), en combinación con 600 mg - 700 mg de paracetamol; c) 6 mg - 8 mg de hidrocloruro de fenilefrina (o una cantidad equivalente de una forma alternativa farmacéuticamente aceptable de fenilefrina), en combinación con 500 mg - 550 mg de paracetamol.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ60665913 | 2013-02-04 | ||
| NZ61013213 | 2013-05-02 | ||
| NZ61391813 | 2013-08-02 | ||
| NZ61802713 | 2013-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP15033649A true ECSP15033649A (es) | 2015-11-30 |
Family
ID=51262632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201533649A ECSP15033649A (es) | 2013-02-04 | 2015-08-03 | Un medicamento combinado que comprende fenilefrina y paracetamol |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP2830605B8 (es) |
| CN (2) | CN104936585B (es) |
| AP (1) | AP2015008704A0 (es) |
| BR (1) | BR112015015938A2 (es) |
| CA (1) | CA2893836C (es) |
| EC (1) | ECSP15033649A (es) |
| LU (1) | LU92526B1 (es) |
| MX (2) | MX381450B (es) |
| MY (1) | MY198201A (es) |
| PE (1) | PE20151282A1 (es) |
| PH (2) | PH12021550907A1 (es) |
| PL (1) | PL2830605T3 (es) |
| RS (1) | RS64807B1 (es) |
| SG (1) | SG11201504389QA (es) |
| TW (1) | TW201434464A (es) |
| WO (1) | WO2014120021A1 (es) |
| ZA (1) | ZA201504080B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
| ES2863988T3 (es) | 2015-05-21 | 2021-10-13 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Formulaciones farmacéuticas con mejor solubilidad y estabilidad |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260600A (en) * | 1979-10-22 | 1981-04-07 | Ronald Valle | Method of treating depression |
| US20040162273A1 (en) * | 2003-01-23 | 2004-08-19 | The Procter & Gamble Company | Powder pharmaceutical compositions |
| GB2443793B (en) | 2006-04-05 | 2010-12-01 | Reckitt Benckiser Healthcare | Product, method of manufacture and use |
| US20070254027A1 (en) * | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| CA2731801C (en) | 2007-07-23 | 2013-11-26 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
| US20090230013A1 (en) * | 2008-03-17 | 2009-09-17 | The Procter & Gamble Company | User-Customizable Dosing System |
| US8518439B2 (en) * | 2008-12-03 | 2013-08-27 | Novartis Ag | Liquid therapeutic composition |
| US20110104272A1 (en) * | 2009-11-05 | 2011-05-05 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| WO2012090218A1 (en) * | 2010-12-30 | 2012-07-05 | Zota Health Care Ltd | Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases |
-
2014
- 2014-01-07 AP AP2015008704A patent/AP2015008704A0/xx unknown
- 2014-01-07 PH PH1/2021/550907A patent/PH12021550907A1/en unknown
- 2014-01-07 PL PL14746905.0T patent/PL2830605T3/pl unknown
- 2014-01-07 CN CN201480003659.0A patent/CN104936585B/zh active Active
- 2014-01-07 BR BR112015015938A patent/BR112015015938A2/pt not_active Application Discontinuation
- 2014-01-07 LU LU92526A patent/LU92526B1/xx active
- 2014-01-07 CA CA2893836A patent/CA2893836C/en not_active Expired - Fee Related
- 2014-01-07 CN CN201711276478.7A patent/CN107811999A/zh active Pending
- 2014-01-07 WO PCT/NZ2014/000001 patent/WO2014120021A1/en not_active Ceased
- 2014-01-07 RS RS20230953A patent/RS64807B1/sr unknown
- 2014-01-07 MY MYPI2015702023A patent/MY198201A/en unknown
- 2014-01-07 SG SG11201504389QA patent/SG11201504389QA/en unknown
- 2014-01-07 MX MX2015009681A patent/MX381450B/es unknown
- 2014-01-07 PE PE2015001231A patent/PE20151282A1/es unknown
- 2014-01-07 EP EP14746905.0A patent/EP2830605B8/en active Active
- 2014-01-29 TW TW103103365A patent/TW201434464A/zh not_active IP Right Cessation
-
2015
- 2015-06-05 PH PH12015501294A patent/PH12015501294A1/en unknown
- 2015-06-05 ZA ZA2015/04080A patent/ZA201504080B/en unknown
- 2015-07-27 MX MX2021001845A patent/MX2021001845A/es unknown
- 2015-08-03 EC ECIEPI201533649A patent/ECSP15033649A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2830605B1 (en) | 2023-09-27 |
| EP2830605B8 (en) | 2023-11-08 |
| EP2830605A1 (en) | 2015-02-04 |
| LU92526B1 (fr) | 2014-12-22 |
| SG11201504389QA (en) | 2015-08-28 |
| WO2014120021A1 (en) | 2014-08-07 |
| MY198201A (en) | 2023-08-10 |
| PH12021550907A1 (en) | 2023-07-17 |
| MX2015009681A (es) | 2016-07-11 |
| MX2021001845A (es) | 2021-05-13 |
| RS64807B1 (sr) | 2023-12-29 |
| CN104936585B (zh) | 2017-11-14 |
| AP2015008704A0 (en) | 2015-09-30 |
| PL2830605T3 (pl) | 2024-02-19 |
| PH12015501294A1 (en) | 2015-08-24 |
| CN107811999A (zh) | 2018-03-20 |
| BR112015015938A2 (pt) | 2017-07-11 |
| CA2893836C (en) | 2017-05-02 |
| PE20151282A1 (es) | 2015-10-04 |
| MX381450B (es) | 2025-03-12 |
| EP2830605A4 (en) | 2015-02-04 |
| CA2893836A1 (en) | 2014-08-07 |
| ZA201504080B (en) | 2016-04-28 |
| CN104936585A (zh) | 2015-09-23 |
| TW201434464A (zh) | 2014-09-16 |
| TWI514998B (es) | 2016-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017010304A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
| CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
| MX2015009772A (es) | Moduladores de receptores nmda de espiro-lactama y sus usos. | |
| CO2018004776A2 (es) | Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana | |
| MX2016010179A (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| CU20190060A7 (es) | Formas de administración farmacéutica que contienen inhibidores de canales task-1 y task-3 útiles en el tratamiento de trastornos respiratorios | |
| EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
| ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| ECSP15033649A (es) | Un medicamento combinado que comprende fenilefrina y paracetamol | |
| EA201991265A1 (ru) | Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат | |
| UY31790A (es) | Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona | |
| UY35890A (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
| ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| AR093252A1 (es) | Composicion farmaceutica oral utilizada como antiparasitaria y antidiarreica y procesos para prepararla | |
| CL2016000543A1 (es) | Uso de pidotimod o sus estereoisómeros y/o sales fisiológicamente aceptables para preparar un medicamento útil en el tratamiento de enfermedades asociadas con la inflamación, donde hay una hiperactivación aberrante de la vía no canónica de nfkb. | |
| MX2015016679A (es) | Formulaciones de agomelatina que comprenden agomelatina en forma de cocristales. | |
| AR095149A1 (es) | Medicamento que comprende fenilefrina y paracetamol | |
| ECSP17008187A (es) | Formas de dosificación farmacéutica | |
| UY36474A (es) | Método para producir liposomas que contienen un ingrediente farmacéutico activo | |
| CR20150363A (es) | Combinación de un medicamento que comprende fenilefrina y paracetamol | |
| CO2018010142A2 (es) | Proceso de preparación de fórmulas solidas de mesalazina | |
| MX2020004403A (es) | Composiciones farmaceuticas que comprenden safinamida. | |
| PE20191820A1 (es) | Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas | |
| CO2019008347A2 (es) | Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla | |
| MX388249B (es) | Composición farmacéutica de desloratadina para ser administrada por vía oral, para el tratamiento de enfermedades relacionadas con la histamina. |